Search results
Another potential indication for Mounjaro, Zepbound
Becker’s Hospital Review· 3 days agoThe trial results could precede another indication for the popular drugs. Mounjaro, a Type 2 diabetes medication, and Zepbound, a weight loss< ...
Evaluating the Investment Potential of Hims & Hers
GuruFocus.com via Yahoo Finance· 15 hours agoThe company presents a high-potential investment opportunity with impressive growth and a scalable business model, though it faces significant...
In memoriam: Dirk Van Dongen
Politico· 3 days agoIF YOU MISSED IT LAST WEEK: The lobbying push to get weight loss drugs like Ozempic covered by Medicare is picking up, our Chelsea Cirruzzo ...
Experimental GLP-1 Med Might Be Breakthrough Against Fatty Liver Disease | FOX 28 Spokane
FOX 28 Spokane· 4 days agoAn experimental ‘supercharged’ form of popular GLP-1 weight-loss meds could help ease fatty liver...
Kidney disease linked to tooth loss in older women
UPI· 2 days agoOlder women with chronic kidney disease might wind up losing so many teeth they aren't able to chew and talk effectively, a new study warns.
My Son’s Ex-Girlfriend Wants to Keep Her Pregnancy. Is That Unfair to Him?
New York Times· 1 day agoThe magazine’s Ethicist columnist on whether a co-parent’s wishes should matter to a pregnant woman. The physical, practical and emotional effects on a woman obliged to carry a child to term ...
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against...
Morningstar· 6 days agoBragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of stockholders of Intel Corporation (NASDAQ ...
John Fetterman treated for bruised shoulder after weekend car accident
The Patriot-News· 3 days agoPennsylvania Sen. John Fetterman was treated at a hospital for a bruised shoulder after a car...
Experimental GLP-1 Med Might Be Breakthrough Against Fatty Liver Disease
US News & World Report· 4 days agoAn experimental 'supercharged' form of popular GLP-1 weight-loss meds could help ease fatty liver disease, a new trial suggests. The drug under development ...
The Zacks Analyst Blog Highlights Stocks recently featured in the blog include: Novo Nordisk,...
Zacks via Yahoo Finance· 4 days agoInherent in any investment is the potential for loss. This material is being provided for...